Neuberger Berman Group
CRSP icon

Neuberger Berman Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,240
Closed -$395K 1764
2021
Q1
$395K Buy
3,240
+648
+25% +$79K ﹤0.01% 1531
2020
Q4
$407K Buy
2,592
+153
+6% +$24K ﹤0.01% 1433
2020
Q3
$211K Buy
+2,439
New +$211K ﹤0.01% 1535